🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 21 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Dublin

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

45
Recruiting now
79
Active studies
Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation
Boston Scientific Corporation · started 2026-07-07
📍 Dublin
NCT07575269 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb · started 2026-03-26
📍 Dublin
NCT07293351 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Ovarian Neoplasms, Ovarian Cancer
Merck Sharp & Dohme LLC · started 2026-02-16
📍 Dublin
NCT07318558 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Merck Sharp & Dohme LLC · started 2026-01-19
📍 Cork · Dublin
NCT07216703 on ClinicalTrials.gov ↗
Recruiting
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Paroxysmal AF, Atrial Arrhythmia, Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices · started 2025-12-11
📍 Dublin
NCT07181590 on ClinicalTrials.gov ↗
Recruiting
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery Disease (CAD)
University College Dublin · started 2025-12-09
📍 Dublin
NCT07401550 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Merck Sharp & Dohme LLC · started 2025-11-26
📍 Cork · Dublin
NCT07227402 on ClinicalTrials.gov ↗
Recruiting
Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor
Cancer, Malignancies Multiple, Terminal Care, Hospice
Our Lady's Hospice and Care Services · started 2025-11-06
📍 Dublin
NCT07512505 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-10-22
📍 Cork · Dublin
NCT07213804 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology · started 2025-10-01
📍 Dublin
NCT05745714 on ClinicalTrials.gov ↗
Recruiting
Obstructive Sleep Apnoea and Difficult Asthma (OSADA)
Asthma (Diagnosis), OSA - Obstructive Sleep Apnea, CPAP Treatment
St. James's Hospital, Ireland · started 2025-09-01
📍 Dublin
NCT07160868 on ClinicalTrials.gov ↗
Recruiting
Harmony TPV EMEA PMS
Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular · started 2025-07-30
📍 Dublin
NCT06906926 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia
Friedreich Ataxia
Biogen · started 2025-06-09
📍 Dublin
NCT06953583 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC · started 2025-05-22
📍 Dublin · Cork
NCT06952504 on ClinicalTrials.gov ↗
Recruiting Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
Eidos Therapeutics, a BridgeBio company · started 2025-05-12
📍 Dublin
NCT06563895 on ClinicalTrials.gov ↗
Recruiting
Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial
Exercise, Healthy Participants, Glucose Variability, Type 1 Diabetes (T1D)
University College Dublin · started 2025-01-28
📍 Dublin
NCT07209930 on ClinicalTrials.gov ↗
Starting soon
Rehab in Mild Stable DCM: Feasibility RCT Comparing Structured Rehabilitation to Clinical Surveillance
Degenerative Cervical Myelopathy
Royal College of Surgeons, Ireland · started 2025-01-13
📍 Dublin
NCT06781658 on ClinicalTrials.gov ↗
Active Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer · started 2025-01-06
📍 Dublin
NCT06760637 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
GlaxoSmithKline · started 2024-12-16
📍 Dublin · Galway · Waterford
NCT06679101 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC · started 2024-10-21
📍 Cork · Dublin
NCT06623422 on ClinicalTrials.gov ↗
Recruiting
A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)
Breast Cancer
Royal College of Surgeons, Ireland · started 2024-10-01
📍 Dublin
NCT07503704 on ClinicalTrials.gov ↗
Active Phase 3
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex · started 2024-08-30
📍 Cork · Dublin · Galway · Waterford
NCT06564142 on ClinicalTrials.gov ↗
Recruiting
Real World Data Collection on the Synergy Disc
Cervical Degenerative Disc Disease
Synergy Spine Solutions · started 2024-08-06
📍 Dublin
NCT06383949 on ClinicalTrials.gov ↗
Recruiting Phase 4
Fibrosis Lessens After Metabolic Surgery
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis
The Cleveland Clinic · started 2024-07-11
📍 Dublin
NCT06374875 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC · started 2024-06-24
📍 Cork · Dublin · Galway
NCT06393374 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Prostatic Neoplasms, Castration-Resistant
Merck Sharp & Dohme LLC · started 2024-05-20
📍 Dublin · Cork
NCT06353386 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo · started 2024-04-10
📍 Dublin · Cork · Galway
NCT06330064 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc · started 2024-03-25
📍 Dublin · Cork
NCT06253871 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Verastem, Inc. · started 2024-03-18
📍 Dublin
NCT06072781 on ClinicalTrials.gov ↗
Active
ProVIDE II Bridging Study
BPH With Symptomatic Lower Urinary Tract Symptoms
ProVerum Medical · started 2024-03-06
📍 Dublin
NCT06236802 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Phenylketonuria
PTC Therapeutics · started 2024-03-04
📍 Dublin
NCT06302348 on ClinicalTrials.gov ↗
Active
Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
Crohn's Disease
AbbVie · started 2024-02-19
📍 Ballinasloe · Dublin
NCT05930275 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
Achondroplasia
Ascendis Pharma A/S · started 2024-01-23
📍 Dublin
NCT06079398 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
Homocystinuria
Travere Therapeutics, Inc. · started 2023-12-28
📍 Dublin
NCT06247085 on ClinicalTrials.gov ↗
Active Phase 2
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
HER2-positive Breast Cancer
Cancer Trials Ireland · started 2023-10-26
📍 Galway · Dublin · Cork · Limerick
NCT05710666 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis
argenx · started 2023-09-12
📍 Dublin
NCT05979441 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Community-acquired Pneumonia
Biotest · started 2023-09-09
📍 Dublin · Galway
NCT05722938 on ClinicalTrials.gov ↗
By invitation Phase 2/Phase 3
A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
Achondroplasia
Ascendis Pharma Growth Disorders A/S · started 2023-06-21
📍 Dublin
NCT05929807 on ClinicalTrials.gov ↗
Active Phase 2
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
NSCLC Stage IV, KRAS P.G12C
ETOP IBCSG Partners Foundation · started 2023-06-12
📍 Dublin · Limerick · Waterford
NCT05673187 on ClinicalTrials.gov ↗
Recruiting
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
Bradycardia, Pacing, Right Ventricular Pacing, His Bundle Pacing
Imperial College London · started 2023-06-05
📍 Dublin
NCT05815745 on ClinicalTrials.gov ↗
By invitation Phase 3
An Open-label Study of XEN1101 in Epilepsy
Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc. · started 2023-04-25
📍 Dublin
NCT05718817 on ClinicalTrials.gov ↗
Active Phase 3
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
Melanoma
Regeneron Pharmaceuticals · started 2023-01-16
📍 Galway · Cork · Dublin
NCT05608291 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Bristol-Myers Squibb · started 2023-01-12
📍 Manorhamilton · Cork · Dublin
NCT05617677 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia
H. Lundbeck A/S · started 2022-12-19
📍 Dublin
NCT05669950 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Greenwich LifeSciences, Inc. · started 2022-12-16
📍 Dublin
NCT05232916 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Gilead Sciences · started 2022-12-12
📍 Dublin · Limerick · Wilton
NCT05633654 on ClinicalTrials.gov ↗
Active
APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
Appetite Loss, Physical Inactivity, Undernutrition, Anorexia of Aging
University College Dublin · started 2022-09-22
📍 Dublin
NCT05608707 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Celgene · started 2022-09-20
📍 Galway · Cork · Dublin · Limerick
NCT05519085 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
Duchenne Muscular Dystrophy (DMD)
Dyne Therapeutics · started 2022-08-12
📍 Dublin
NCT05524883 on ClinicalTrials.gov ↗
Active Phase 3
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
Melanoma
Regeneron Pharmaceuticals · started 2022-07-14
📍 Galway · Cork · Dublin
NCT05352672 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
AstraZeneca · started 2022-04-14
📍 Dublin · Galway
NCT05061550 on ClinicalTrials.gov ↗
Active Phase 3
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC · started 2022-03-24
📍 Dublin
NCT05224141 on ClinicalTrials.gov ↗
Active
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
Metabolic Disease, Obesity & Overweight
University College Dublin · started 2022-02-17
📍 Dublin
NCT07457424 on ClinicalTrials.gov ↗
Active Phase 2
Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
PIK3CA-related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals · started 2022-01-27
📍 Dublin
NCT04980833 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Washington University School of Medicine · started 2021-12-22
📍 Dublin
NCT05269394 on ClinicalTrials.gov ↗
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Down Syndrome, Alzheimer Disease, Dementia
University of Southern California · started 2021-06-07
📍 Dublin
NCT04165109 on ClinicalTrials.gov ↗
Recruiting
FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study
Hyperandrogenism, Metabolic Disease, Sex Hormones Adverse Reaction
Royal College of Surgeons, Ireland · started 2021-04-01
📍 Dublin
NCT04912648 on ClinicalTrials.gov ↗
Active Phase 3
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
Hemophilia A
Bioverativ, a Sanofi company · started 2021-02-23
📍 Dublin
NCT04644575 on ClinicalTrials.gov ↗
Recruiting
iCorMicA - Stratified Medicine in Angina
Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD)
NHS Greater Glasgow and Clyde · started 2020-12-30
📍 Cork · Dublin
NCT04674449 on ClinicalTrials.gov ↗
Recruiting Phase 2
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Cancer Trials Ireland · started 2020-12-22
📍 Dublin
NCT04375904 on ClinicalTrials.gov ↗
Recruiting Phase 3
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Esophageal Squamous Cell Carcinoma
Karolinska University Hospital · started 2020-11-27
📍 Dublin
NCT04460352 on ClinicalTrials.gov ↗
Recruiting Phase 3
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries
Australian and New Zealand Intensive Care Research Centre · started 2020-11-09
📍 Beaumont · Cork · Dublin
NCT04588311 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Leukemia, Acute Lymphoblastic
Mats Heyman · started 2020-07-13
📍 Dublin
NCT04307576 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. · started 2020-07-13
📍 Dublin
NCT03992430 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Hypertension, Pulmonary
Actelion · started 2020-01-16
📍 Dublin
NCT04175600 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland · started 2019-12-20
📍 Cork · Dublin · Galway · Limerick
NCT04027309 on ClinicalTrials.gov ↗
Active Phase 3
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals · started 2019-11-26
📍 Dublin
NCT04153149 on ClinicalTrials.gov ↗
Active Phase 3
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology · started 2019-09-20
📍 Cork · Dublin
NCT04095364 on ClinicalTrials.gov ↗
By invitation
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
Paget Disease
University of Edinburgh · started 2019-04-05
📍 Dublin
NCT03859895 on ClinicalTrials.gov ↗
Active Phase 3
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
Hemophilia
Genzyme, a Sanofi Company · started 2019-01-09
📍 Crumlin · Dublin
NCT03754790 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Progressive Multiple Sclerosis (PMS)
Hoffmann-La Roche · started 2018-05-28
📍 Cork · Dublin
NCT03523858 on ClinicalTrials.gov ↗
Active Phase 3
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
Pre-Exposure Prophylaxis of HIV-1 Infection
Gilead Sciences · started 2016-09-02
📍 Dublin
NCT02842086 on ClinicalTrials.gov ↗
Active Phase 3
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
Oropharyngeal Cancer
University of Birmingham · started 2015-07
📍 Dublin
NCT04116047 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Brain Tumors
Universitätsklinikum Hamburg-Eppendorf · started 2014-06
📍 Dublin
NCT02066220 on ClinicalTrials.gov ↗
Active
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Stage IB Breast Cancer, Stage II Breast Cancer
NSABP Foundation Inc · started 2013-08
📍 Dublin · Galway
NCT01872975 on ClinicalTrials.gov ↗
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc. · started 2013-05-30
📍 Dublin
NCT01633489 on ClinicalTrials.gov ↗
Active Phase 3
Prostate Advances in Comparative Evidence
Prostate Cancer
Royal Marsden NHS Foundation Trust · started 2012-08-07
📍 Dublin
NCT01584258 on ClinicalTrials.gov ↗
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
CHDI Foundation, Inc. · started 2012-07
📍 Dublin
NCT01574053 on ClinicalTrials.gov ↗
Active Phase 2
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Prostate Cancer
Cancer Trials Ireland · started 2009-07-20
📍 Cork · Dublin
NCT00951535 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 79 Cork · 27 Galway · 17 Limerick · 8 Crumlin · 4 Waterford · 3 Beaumont · 3 Ballinasloe · 1 Manorhamilton · 1 Wilton · 1 Greystones · 1 Sligo · 1

Browse by condition

Cancer · 3 Breast Cancer · 3 Prostate Cancer · 3 Melanoma · 2 Ovarian Neoplasms · 2 Vascular Diseases · 2 Metabolic Disease · 2 Multiple Myeloma · 2 HER2-positive Breast Cancer · 2 Dementia · 2 Achondroplasia · 2 Persistent Atrial Fibrillation · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/dublin (Accessed: 21 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.